Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical deterioration | clinical improvement | deaths | viral clearance | |||
| anticoagulant | 0.69 [0.43; 1.10], 1 RCT, I2=0% inconclusive result | - | 0.49 [0.13; 1.87], 2 RCTs, I2=82% inconclusive result | - | ||
| face mask | 0 | - | - | - | - | |
| febuxostat | 0 | - | - | - | - | |
| hydrogen-oxygen nebulizer | 0 | - | - | - | - | |
| hyperbaric oxygen | 0 | - | - | - | - | |
| nintedanib | 0 | - | - | - | - | |
| paracetamol | 0 | - | - | - | - | |
| pulmonary rehabilitation | 0 | - | - | - | - | |
| respiratory support | 0 | - | - | - | - | |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
